Jinling Hospital
Nanjing, Jiangsu, China
NCT Number: NCT06498778
The investigators retrospectively collected participants with spontaneous cerebral hemorrhage(sICH) from January 2015 to December 2019 for training and internal validation. Clinical and imaging data were collected. Modified Rankin Scale (mRS) scores were determined good outcome as "mRS = 0-2", poor outcome as "mRS = 3-6". The location features of sICH were extracted by symptom mapping. Noncontrast computed tomography images of patients and hematoma masks were registered with standard human brain templates to identify specific affected brain regions. Then a probability map of hemorrhage for different causes and prognosis is generated. PyRadiomics was used to extract the radiomic features, integrate radiomic and clinical features into multiple logistic regression models, and develop and validate optimal etiological and prognostic models. Further tests were performed in an independent cohort. The area under the working characteristic curve (AUC), sensibility, specificity were used to evaluate the reliability of the model.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Nanjing, Jiangsu, China
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: follow-ups at twelve months post sICH event
Good outcome as "mRS = 0-2", poor outcome as "mRS = 3-6"
Jinling Hospital, China
Other
Prediction of Etiology and Prognosis Based on Hematoma Location of Spontaneous Intracerebral Hemorrhage
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04820972
Spontaneous Intracerebral Hemorrhage
Beijing, Beijing Municipality, China
View Trial DetailsNCT03183167
Spontaneous Intracerebral Hemorrhage
Erlangen, Germany
View Trial DetailsNCT07710313
Basal Ganglia Cerebrovascular Disease, Basal Ganglia Diseases
View Trial DetailsNCT06763055
Acute Stroke, Acute intraCerebral Haemorrhage
Sydney, New South Wales, Australia
View Trial Details